Effect of 17#beta#--estradiol on secretion of the chemokines IL--8,MIP--1#alpha#,RANTES and I--309 by endometrial stromal cells in vitro

In: Zhongguo mianyixue zazhi · 2005 · vol. 21(12) , pp. 928–931 · W2376684989
article OA: closed CC0
View on OpenAlex
AI-generated summary by claude@2026-06, 2026-06-07

17#beta#-estradiol increased IL-8 and MIP-1#alpha# secretion by endometrial stromal cells in a concentration-dependent manner but did not affect RANTES or I-309 secretion.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To elucidate the role of estradiol in the pathogenesis and development of endometriosis by exploring the effects of 17#beta#-estradiol on IL-8,MIP-1#alpha#, RANTES and I-309 secretion by endometrial stromal cells. IL-8,MIP-1#alpha#,RANTES and I-309 protein in culture supernatant of endometrial stromal cells after treated by 17#beta#-estradiol with different concentrations for 48 h or for 12-48 h with 10~(-9) mol/L were quantified using ELISA kits of R&D systems. The endometrial stromal cells in vitro secretion in a concentration-dependent manner (P<0.05), but did not affect RANTES secretion. Human endometrial stromal cells did not secrete the chemokine I-309 protein whether treated with estradiol or not. The estradiol may recruit endometrial macrophage and leukocytes migration by regulating IL-8 and MIP-1#alpha# secretion of endometrial stromal cells,and alone is not account for the increased expression of IL-8,RANTES and MIP-1#alpha# in the ectopic tissue of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK